Guardant Health


Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

United States


View Employees

Sean Curran
Associate Director, Service Desk at Guardant Health
Mort Minaee
Vice President Regulatory Affairs at Guardant Health
Marcel Roche
VP Finance & Controller at Guardant Health
Rohit Saini
Senior Director of Supply Chain at Guardant Health
Mike Bell
Chief Financial Officer at Guardant Health
Marcin Sikora
Manager, Bioinformatics at Guardant Health
Sharon Anne Ricafrente
Senior Clinical Lab Scientist at Guardant Health
Karri Voytilla
Customer Service Consultant at Guardant Health

Find more contacts